Abstract
Advances in analytical methodologies, principally nuclear magnetic resonance spectroscopy (NMR) and mass spectrometry (MS), over the last decade have made large-scale analysis of the human metabolome a reality. This is leading to the reawakening of the importance of metabolism in human diseases, particularly widespread metabolic diseases such as cancer, diabetes, and obesity. Emerging NMR and MS atom-tracking technologies and informatics are poised to revolutionize metabolomics-based research because they deliver the high information throughput (HIT) that is needed for deciphering systems biochemistry. In particular, stable isotope-resolved metabolomics (SIRM) enables unambiguous tracking of individual atoms through compartmentalized metabolic networks in a wide range of experimental systems, including human subjects. MS offers a wide range of instrumental capabilities involving different levels of initial capital outlay and operating costs, ranging from gas-chromatography (GC) MS that is affordable by many individual laboratories to the HIT-supporting Fourier-transform (FT) class of MS that rivals NMR in cost and infrastructure support. This chapter focuses on sample preparation, instrument, and data processing procedures for these two extremes of MS instrumentation used in SIRM.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Schlotterbeck G, Ross A, Dieterle F, Senn H (2006) Metabolic profiling technologies for biomarker discovery in biomedicine and drug development. Pharmacogenomics 7:1055–1075
Oresic M, Vidal-Puig A, Hanninen V (2006) Metabolomic approaches to phenotype characterization and applications to complex diseases. Expert Rev Mol Diagn 6:575–585
Dunn W, Broadhurst D, Deepak S, Buch M, McDowell G, Spasic I, Ellis D, Brooks N, Kell D, Neyses L (2007) Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate. Metabolomics 3:413–426
Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457:910–914
Griffiths WJ, YuqinWang TK, Kohl M, Enot DP, Deigner H-P (2010) Targeted metabolomics for biomarker discovery. Angew Chem Int Ed 49:5426–5446
Theodoridis G, Gika HG, Wilson ID (2011) Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies. Mass Spectrom Rev 30:884–906
Want EJ, Smith CA, Qin CA, VanHorne KC, Siuzdak G (2006) Phospholipid capture combined with non-linear chromatographic correction for improved serum metabolite profiling. Metabolomics 2:145–154
Clayton TA, Lindon JC, Cloarec O, Antti H, Charuel C, Hanton G, Provost J-P, Le Net J-LØ, Baker D, Walley RJ, Everett JR, Nicholson JK (2006) Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440:1073–1077
Harrigan GG, Brackett DJ, Boros LG (2005) Medicinal chemistry, metabolic profiling and drug target discovery: a role for metabolic profiling in reverse pharmacology and chemical genetics. Mini Rev Med Chem 5:13–20
Boros LG (2005) Metabolic targeted therapy of cancer: current tracer technologies and future drug design strategies in the old metabolic network. Metabolomics 1:11–15
Fan TWM, Higashi RM, Lane AN (2006) Integrating metabolomics and transcriptomics for probing Se anticancer mechanisms. Drug Metab Rev 38:707–732
Robertson DG (2005) Metabonomics in toxicology: a review. Toxicol Sci 85:809–822
Griffin JL, Bollard ME (2004) Metabonomics: its potential as a tool in toxicology for safety assessment and data integration. Curr Drug Metab 5:389–398
Chen C, Gonzalez FJ, Idle JR (2007) LC-MS-based metabolomics in drug metabolism. Drug Metab Rev 39:581–597
Fan TWM, Lorkiewicz P, Sellers K, Moseley HNB, Higashi RM, Lane AN (2012) Stable isotope-resolved metabolomics and applications for drug development. Pharmacol Ther 133:366–391
Lane AN, Fan TW, Higashi RM (2008) Isotopomer-based metabolomic analysis by NMR and mass spectrometry. Methods Cell Biol 84:541–588
Fan TW, Lane AN, Higashi RM, Farag MA, Gao H, Bousamra M, Miller DM (2009) Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM). Mol Cancer 8:41
Fan TW-M, Yuan P, Lane AN, Higashi RM, Wang Y, Hamidi A, Zhou R, Guitart X, Chen G, Manji HKM, Kaddurah-Daouk R (2010) Stable isotope-resolved metabolomic analysis of lithium effects on glial-neuronal metabolism and interactions. Metabolomics 6:165–179
Zamboni N, Fendt SM, Ruhl M, Sauer U (2009) (13)C-based metabolic flux analysis. Nat Protoc 4:878–892
Fan T, Lane A, Higashi R, Yan J (2011) Stable isotope resolved metabolomics of lung cancer in a SCID mouse model. Metabolomics 7:257–269
Moseley H, Lane A, Belshoff A, Higashi R, Fan T (2011) A novel deconvolution method for modeling UDP-GlcNAc biosynthetic pathways based on 13C mass isotopologue profiles under non steady-state conditions. BMC Biol 9:37
Hiller K, Metallo C, Stephanopoulos G (2011) Elucidation of cellular metabolism via metabolomics and stable-isotope assisted metabolomics. Curr Pharm Biotechnol 12:1075–1086
Fan TW, Lane AN (2011) NMR-based stable isotope resolved metabolomics in systems biochemistry. J Biomol NMR 49:267–280
Lorkiewicz PK, Higashii RM, Lane AN, Fan TW-M (2011) High information throughput analysis of nucleotides and their isotopically enriched isotopologues by direct-infusion FTICR-MS. Metabolomics 8:930–939
Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, Tsukamoto T, Rojas CJ, Slusher BS, Zhang H, Zimmerman LJ, Liebler DC, Slebos RJC, Lorkiewicz PK, Higashi RM, Fan TWM, Dang CV (2012) Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab 15:110–121
Boros LG, Lerner MR, Morgan DL, Taylor SL, Smith BJ, Postier RG, Brackett DJ (2005) [1,2-13C2]-D-glucose profiles of the serum, liver, pancreas, and DMBA-induced pancreatic tumors of rats. Pancreas 31:337–343
Bian F, Kasumov T, Thomas KR, Jobbins KA, David F, Minkler PE, Hoppel CL, Brunengraber H (2005) Peroxisomal and mitochondrial oxidation of fatty acids in the heart, assessed from the C-13 labeling of malonyl-CoA and the acetyl moiety of citrate. J Biol Chem 280:9265–9271
Olszewski KL, Mather MW, Morrisey JM, Garcia BA, Vaidya AB, Rabinowitz JD, Llinas M (2010) Branched tricarboxylic acid metabolism in Plasmodium falciparum. Nature 466:774–778
Fan TW-M, Lane AN, Higashi RM (2004) The promise of metabolomics in cancer molecular therapeutics. Curr Opin Mol Ther 6:584–592
Arita M. Personal Communication from metabolome database download
Moseley HNB (2013) Error analysis and propagation in metabolomics data analysis. Comp Struct Biotechnol J 4:e201301006
Fan TWM, Higashi RM, Lane AN, Jardetzky O (1986) Combined use of proton NMR and gas chromatography-mass spectra for metabolite monitoring and in vivo proton NMR assignments. Biochim Biophys Acta 882:154–167
Fiehn O, Kopka J, Dormann P, Altmann T, Trethewey RN, Willmitzer L (2000) Metabolite profiling for plant functional genomics. Nat Biotechnol 18:1157–1161
Kind T, Meissen JK, Yang D, Nocito F, Vaniya A, Cheng YS, Vandergheynst JS, Fiehn O (2012) Qualitative analysis of algal secretions with multiple mass spectrometric platforms. J Chromatogr A 1244:139–147
Budczies J, Denkert C, Muller BM, Brockmoller SF, Klauschen F, Gyorffy B, Dietel M, Richter-Ehrenstein C, Marten U, Salek RM, Griffin JL, Hilvo M, Oresic M, Wohlgemuth G, Fiehn O (2012) Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue—a GC-TOFMS based metabolomics study. BMC Genomics 13:334
Liu W, Le A, Hancock C, Lane AN, Dang CV, Fan TW, Phang JM (2012) Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc Natl Acad Sci U S A 109:8983–8988
Dong C, Yuan T, Wu Y, Wang Y, Fan TW, Miriyala S, Lin Y, Yao J, Shi J, Kang T, Lorkiewicz P, St Clair D, Hung MC, Evers BM, Zhou BP (2013) Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 23:316–331
Yoo H, Antoniewicz MR, Stephanopoulos G, Kelleher JK (2008) Quantifying reductive carboxylation flux of glutamine to lipid in a brown adipocyte cell line. J Biol Chem 283:20621–20627
Vizan P, Boros LG, Figueras A, Capella G, Mangues R, Bassilian S, Lim S, Lee WN, Cascante M (2005) K-ras codon-specific mutations produce distinctive metabolic phenotypes in NIH3T3 mice [corrected] fibroblasts. Cancer Res 65:5512–5515
Lee WN, Boros LG, Puigjaner J, Bassilian S, Lim S, Cascante M (1998) Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1,2-13C2]glucose. Am J Physiol 274:E843–E851
Lee WN, Go VL (2005) Nutrient-gene interaction: tracer-based metabolomics. J Nutr 135:3027S–3032S
Yang TH, Wittmann C, Heinzle E (2006) Respirometric 13C flux analysis—Part II: in vivo flux estimation of lysine-producing Corynebacterium glutamicum. Metab Eng 8:432–446
Lee PNW, Wahjudi PN, Xu J, Go VL (2010) Tracer-based metabolomics: concepts and practices. Clin Biochem 43:1269–1277
Fan TWM, Higashi RM, Frenkiel TA, Lane AN (1997) Anaerobic nitrate and ammonium metabolism in flood-tolerant rice coleoptiles. J Exp Bot 48:1655–1666
Fan TW-M, Lane AN, Higashi RM (2012) The handbook of metabolomics, vol 17. Springer, New York
Moseley H (2010) Correcting for the effects of natural abundance in stable isotope resolved metabolomics experiments involving ultra-high resolution mass spectrometry. BMC Bioinform 11:139
Fan TWM, Colmer TD, Lane AN, Higashi RM (1993) Determination of metabolites by proton NMR and GC analysis for organic osmolytes in crude tissue extracts. Anal Biochem 214:260–271
Gradwell MJ, Fan TWM, Lane AN (1998) Analysis of phosphorylated metabolites in crayfish extracts by two-dimensional 1H-31P NMR heteronuclear total correlation spectroscopy (hetero TOCSY). Anal Biochem 263:139–149
Fan T, Bandura L, Higashi R, Lane A (2005) Metabolomics-edited transcriptomics analysis of Se anticancer action in human lung cancer cells. Metabolomics 1:325–339
Lane AN, Fan TW-M (2007) Quantification and identification of isotopomer distributions of metabolites in crude cell extracts using 1H TOCSY. Metabolomics 3:79–86
Fan TW-M (ed) (2010) Metabolomics-edited transcriptomics analysis (meta), vol 2. Academic, Oxford
Fan TW-M, Tan JL, McKinney MM, Lane AN (2012) Stable isotope resolved metabolomics analysis of ribonucleotide and RNA metabolism in human lung cancer cells. Metabolomics 8:517–527
Yuneva MO, Fan TW-M, Higashi RM, Allen TA, Balakrishnan A, Goga A, Ferraris DV, Tsukamoto T, Wang C, Seo Y, Chen X, Bishop JM (2012) The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab 15:157–170
Fan TW-M (2012) Sample preparation for metabolomics investigation. In: Fan TW-M, Lane AN, Higashi RM (eds) The handbook of metabolomics: pathway and flux analysis, Methods in pharmacology and toxicology. Springer Science, New York, pp 7–27
Mattingly SJ, Xu T, Nantz MH, Higashi RM, Fan TW-M (2012) A carbonyl capture approach for profiling oxidized metabolites in cell extracts. Metabolomics 8:989–996
Lane AN, Fan TW-M, Xie X, Moseley HN, Higashi RM (2009) Stable isotope analysis of lipid biosynthesis by high resolution mass spectrometry and NMR. Anal Chim Acta 651:201–208
Stadtman TC (1996) Selenocysteine. Annu Rev Biochem 65:83–100
Stadtman TC (2000) Selenium biochemistry—mammalian selenoenzymes. In: Reactive oxygen species: from radiation to molecular biology. New York Acad. Sci, New York, pp 399–402
Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, Srivas R, Palsson BO (2007) Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci U S A 104:1777–1782
Allwood JW, Erban A, de Koning S, Dunn WB, Luedemann A, Lommen A, Kay L, Loscher R, Kopka J, Goodacre R (2009) Inter-laboratory reproducibility of fast gas chromatography-electron impact-time of flight mass spectrometry (GC-EI-TOF/MS) based plant metabolomics. Metabolomics 5:479–496
Fan TW-M (2010) Metabolomics-edited transcriptomics analysis (meta). In: McQueen CA (ed) Comprehensive toxicology. Academic, Oxford, pp 685–706
Want EJ, O’Maille G, Smith CA, Brandon TR, Uritboonthai W, Qin C, Trauger SA, Siuzdak G (2006) Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal Chem 78:743–752
Villas-Boas SG, Hojer-Pedersen J, Akesson M, Smedsgaard J, Nielsen J (2005) Global metabolite analysis of yeast: evaluation of sample preparation methods. Yeast 22:1155–1169
Winder CL, Dunn WB, Schuler S, Broadhurst D, Jarvis R, Stephens GM, Goodacre R (2008) Global metabolic profiling of Escherichia coli cultures: an evaluation of methods for quenching and extraction of intracellular metabolites. Anal Chem 80:2939–2948
Sellick CA, Hansen R, Maqsood AR, Dunn WB, Stephens GM, Goodacre R, Dickson AJ (2009) Effective quenching processes for physiologically valid metabolite profiling of suspension cultured mammalian cells. Anal Chem 81:174–183
Bolten CJ, Kiefer P, Letisse F, Portais JC, Wittmann C (2007) Sampling for metabolome analysis of microorganisms. Anal Chem 79:3843–3849
de Koning W, van Dam K (1992) A method for the determination of changes of glycolytic metabolites in yeast on a subsecond time scale using extraction at neutral pH. Anal Biochem 204:118–123
Buchholz A, Hurlebaus J, Wandrey C, Takors R (2002) Metabolomics: quantification of intracellular metabolite dynamics. Biomol Eng 19:5–15
Daykin CA, Foxall PJD, Connor SC, Lindon JC, Nicholson JK (2002) The comparison of plasma deproteinization methods for the detection of low-molecular-weight metabolites by H-1 nuclear magnetic resonance spectroscopy. Anal Biochem 304:220–230
Rabinowitz JD, Kimball E (2007) Acidic acetonitrile for cellular metabolome extraction from Escherichia coli. Anal Chem 79:6167–6173
Acknowledgements
This work was supported in part by National Science Foundation EPSCoR grants# EPS-0447479 (T.W.M.F.) and EPS-0132295 (R.J. Wittebort), NIH NCRR 5P20RR018733 (D.M. Miller, A.N.L.), 1R01CA118434-01A2, 1RO1CA101199-01, R01ES-022191-01 and 3R01CA118434-02S1 (T.W.M.F.), R21CA133-668-02, and P01CA163223-01A1 (A.N.L.) from the National Cancer Institute, the University of Louisville CTSPGP/ARRA grants 20044, the Kentucky Lung Cancer Research Program (OGMB090354B1 and OGMB101380) (T.W.M.F. and A.N.L.), the Robert W. Rounsavall Jr. Family Foundation, and the Kentucky Challenge for Excellence. We thank Jin Lian Tan, Alex Belshoff, Katherine Sellers, and Radhika Burra for technical assistance and/or comments on the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Higashi, R.M., Fan, T.WM., Lorkiewicz, P.K., Moseley, H.N.B., Lane, A.N. (2014). Stable Isotope-Labeled Tracers for Metabolic Pathway Elucidation by GC-MS and FT-MS. In: Raftery, D. (eds) Mass Spectrometry in Metabolomics. Methods in Molecular Biology, vol 1198. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1258-2_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1258-2_11
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1257-5
Online ISBN: 978-1-4939-1258-2
eBook Packages: Springer Protocols